- Re: Hong et al.: Ocular Outcomes with Tirzepatide versus Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes (Ophthalmol Retina. 2026;10:625-632). [Letter]Ophthalmol Retina. 2026 Oct 07. [Online ahead of print]OR
- Publisher Full Text (DOI)
- REPLY. [Letter]Ophthalmol Retina. 2026 Oct 08. [Online ahead of print]OR
- Publisher Full Text (DOI)
- The Continuing Challenge of Postoperative Tilt Following the Yamane Technique. [Editorial]Ophthalmol Retina. 2026 Oct 08. [Online ahead of print]OR
- Publisher Full Text (DOI)
- Prophylactic Retinopexy in the Fellow Eye after Contralateral Retinal Detachment: Beyond the Pooled Estimate. [Editorial]Ophthalmol Retina. 2026 Oct 07. [Online ahead of print]OR
- Publisher Full Text (DOI)
- An Iatrogenic Iridodialysis from Misdirected Intravitreal Injection. [Journal Article]Ophthalmol Retina. 2026 Oct 07. [Online ahead of print]OR
- Publisher Full Text (DOI)
- Re: Pandiri et al.: Telemedicine utilization for retinopathy of prematurity screening in premature infants: Systematic review and meta-analysis. [Letter]Ophthalmol Retina. 2026 Oct 08. [Online ahead of print]OR
- Publisher Full Text (DOI)
- Vertical Hyperreflective Columns in Ocular Sarcoidosis. [Journal Article]Ophthalmol Retina. 2026 Oct 08. [Online ahead of print]OR
- Publisher Full Text (DOI)
- Reassessing Fellow-Eye Risk in Retinal Artery Occlusions. [Editorial]Ophthalmol Retina. 2026 Oct 08. [Online ahead of print]OR
- Publisher Full Text (DOI)
- Management of Neovascular Age-Related Macular Degeneration in Routine US Clinical Practice: Impact of Delayed Treatment Initiation. [Journal Article]Ophthalmol Retina. 2026 Oct 07. [Online ahead of print]OR
- CONCLUSIONS: Overall, approximately one-quarter of eyes with nAMD were not treated within 29 days of diagnosis. Simultaneous bilateral nAMD diagnosis and poor baseline VA (< 20/400) were primary factors associated with not receiving anti-VEGF treatment. Greater VA gains were observed with prompt treatment and increasing number of injections.
- Publisher Full Text (DOI)
- Outcomes of Eyes with Concurrent Suprachoroidal Hemorrhage and Retinal Detachment: A Multicenter Study. [Journal Article]Retina. 2026 Sep 30. [Online ahead of print]R
- CONCLUSIONS: Eyes with SCH-RD have guarded visual prognoses, especially when PVR is present. Undergoing multiple surgeries for RD repair and the absence of PVR were associated with greater odds of achieving retinal attachment.
- Publisher Full Text (DOI)
- Structure-Function Relationships in Retinitis Pigmentosa: Three-Year Changes in Visual Function and Outer Retinal Layers. [Journal Article]Retina. 2026 Sep 30. [Online ahead of print]R
- CONCLUSIONS: Distinct outer retinal biomarkers were differentially associated with functional measures in RP. Repeated EZW measurements were most strongly associated with VFI, whereas repeated OS thickness measurements were most closely associated with BCVA. ONL shows measurable structural loss but limited functional relevance. Multilayer structural assessment provides complementary information on RP progression and may help refine future clinical evaluation strategies.
- Publisher Full Text (DOI)
- A Multi-Institutional Study on West Nile Virus Uveitis: Treatment, Complications, and Long-Term Outcomes. [Journal Article]Retina. 2026 Sep 30. [Online ahead of print]R
- CONCLUSIONS: WNV uveitis often has a self-limited course but can be intractable in some patients, with long-term control needed for CME and retinal vasculitis with systemic IMT. Ophthalmologists must be aware of the rarer complications that may require intervention.
- Publisher Full Text (DOI)
- Perfusion Density Changes After Epiretinal Membrane Surgery Predominantly Reflect Topographic Redistribution of Macular Vasculature. [Journal Article]Retina. 2026 Sep 29. [Online ahead of print]R
- CONCLUSIONS: In iERM, greater FAZ enlargement correlated with greater visual improvement despite a reduction in central PD. The significant relationship between changes in FV and PD suggests that changes in OCTA flow parameters after iERM surgery predominantly reflect topographic redistribution of macular vasculature rather than a true loss of perfusion, although a concurrent perfusion change cannot be entirely excluded.
- Publisher Full Text (DOI)
- Anti-Vascular Endothelial Growth Factor Injection-to-Surgery Interval in Diabetic Vitrectomy: A Systematic Review and Meta-Analysis. [Review]Ophthalmol Retina. 2026 Sep 28. [Online ahead of print]OR
- CONCLUSIONS: Preoperative anti-VEGF is associated with less intraoperative and early postoperative hemorrhage and fewer reoperations at diabetic vitrectomy, with the lowest hemorrhage rates when injection precedes surgery by 1 to 7 days. The evidence does not identify a precise optimal interval; higher TRD and reoperation rates beyond 14 days derive from a single cohort. Interval associations are hypothesis-generating given observational, low-certainty evidence.
- Publisher Full Text (DOI)
- Re: Modjtahedi et al. Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology's Task Force (Ophthalmol Retina. 2025;9:1005-1016). [Letter]Ophthalmol Retina. 2026 Sep 25. [Online ahead of print]OR
- Publisher Full Text (DOI)